»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Biological PCR Technology Market, By Product Type, By Technique, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1756452
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 392 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,449,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,366,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,735,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 146¾ï 3,454¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³â CAGR 7.2%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå - ½ÃÀå ¿ªÇÐ

½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡ÇÏ´Â °ÍÀº »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¹Ì·®ÀÇ À¯Àü¹°ÁúÀ» ³ôÀº ƯÀ̼ºÀ¸·Î °ËÃâÇÏ´Â PCRÀÇ ´É·ÂÀº Äڷγª19, HIV, °áÇÙÀ» Æ÷ÇÔÇÑ °¨¿°º´ Áø´Ü¿¡ ÀÖ¾î ¸Å¿ì ±ÍÁßÇÕ´Ï´Ù. ¼¼°è ÀÇ·á Á¦µµ°¡ Áúº´ÀÇ Á¶±â ¹ß°ß ¹× ¸ÂÃãÇü ÀǷḦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ÀÓ»ó Áø´Ü¿¡¼­ PCRÀÇ ¿ªÇÒÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀÚ±Ý Á¦°øÀÇ Áõ°¡¿Í PCR ÀåÄ¡ÀÇ ±â¼úÀû Áøº¸´Â º´¿ø, ·¦, ¿¬±¸±â°ü Àüü¿¡ ´ëÇÑ Ã¤¿ëÀ» ´õ¿í °­È­ÇØ ¼¼°è ½ÃÀåÀÇ ²ÙÁØÇÑ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®¿¡ µû¸£¸é ¼¼°èÀÇ »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº 2024-2032³â ¾à 7.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¹ßÀüÇÒ Àü¸ÁÀÔ´Ï´Ù.

Á¦Ç° À¯Çüº°·Î 2024³â ½Ã¾à Ä«Å×°í¸®°¡ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

±â¼úº°·Î 2024³â ½Ç½Ã°£ PCR(qPCR) ºÎ¹®ÀÌ °¡Àå ¼öÀÍÀ» ¿Ã·È½À´Ï´Ù.

Áö¿ªº°·Î´Â 2024³â ºÏ¹Ì°¡ °¡Àå ¼öÀÍÀÌ ³ôÀº Áö¿ªÀ̾ú½À´Ï´Ù.

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº 5°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Á¦Ç° À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªÀÔ´Ï´Ù.

Á¦Ç° À¯Çüº°·Î »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº ½Ã¾à, ¼Ò¸ðǰ, ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß ½Ã¾àÀº DNA ÇÁ¶óÀ̸Ó, ´ºÅ¬·¹¿ÀƼµå, ¿ÏÃæÁ¦, È¿¼Ò¸¦ Æ÷ÇÔÇÑ ¸ðµç PCR ¹ÝÀÀ¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸¿Í Áø´Ü ¿ëµµ ¸ðµÎ¿¡¼­ ½Ã¾àÀÇ »ç¿ë ºóµµ°¡ ³ô±â ¶§¹®¿¡ ¾ÈÁ¤ÀûÀÎ ¼ö¿ä°¡ º¸ÀåµË´Ï´Ù. °Ô´Ù°¡ Àü¿°º´ °Ë»ç, À¯ÀüÀÚ ¿¬±¸ ¹× ¸ÂÃãÇü ÀÇ·á Áõ°¡´Â ¼¼°èÀûÀ¸·Î PCR °Ë»çÀÇ ¾çÀ» Å©°Ô Áõ°¡½ÃŰ°í ½Ã¾à ¼Òºñ¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. PCR Æ©ºê ¹× Ç÷¹ÀÌÆ®¿Í °°Àº ¼Ò¸ðǰÀº ÇʼöÀûÀÌ¸ç ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º´Â µ¥ÀÌÅÍ ºÐ¼® ¹× ¿öÅ©Ç÷οì ÀÚµ¿È­¿¡ ±â¿©ÇÏÁö¸¸, ½Ã¾àÀº ½ÇÇè½Ç ¹× ÀÓ»ó ÇöÀå ÀüüÀÇ PCR ±â¹Ý ÇÁ·Î¼¼½º¿¡¼­ ÇʼöÀûÀΠƯ¼ºÀ» °¡Áö°í Àֱ⠶§¹®¿¡ °¡Àå ¼öÀͼºÀÌ ³ôÀº ºÎ¹®ÀÔ´Ï´Ù.

±â¼úº°·Î »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº ½Ç½Ã°£ PCR, ÀüÅëÀûÀÎ PCR, µðÁöÅÐ PCR, ¿ªÀü»ç PCR, ÇÖ ½ºÅ¸Æ® PCR, ¸ÖƼÇ÷º½º PCR ¹× ±âŸ PCR ±â¼ú·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß Real-Time PCR(qPCR)Àº °í°¨µµ, °í¼Ó, Á¤·®¼ºÀ¸·Î ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. DNA ÁõÆøÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϸç ÀÓ»ó Áø´Ü, °¨¿°Áõ °ËÃâ, À¯ÀüÀÚ ¹ßÇö ºÐ¼®¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. COVID-19 °Ë»ç¿¡ ³Î¸® »ç¿ëµÊÀ¸·Î½á ¼¼°è ä¿ëÀÌ Å©°Ô °¡¼ÓµÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ ÀÚµ¿È­¿Í µ¥ÀÌÅÍ ºÐ¼® Åø °£ÀÇ ÅëÇÕÀÇ ¹ßÀüÀ¸·Î qPCRÀº º¸´Ù »ç¿ëÇϱ⠽±°í ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ´Ù¸¥ ±â¼úÀº Æ´»õ ¿ëµµ¸¦ °¡Áö°í ÀÖÁö¸¸ Real-Time PCRÀº Á¤È®¼º, È¿À²¼º, ¿¬±¸ ¹× Áø´Ü ¼³Á¤ ¸ðµÎ¿¡¼­ ´Ù¿ëµµ·Î ÀÎÇØ °¡Àå ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº ºÏ¹Ì, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¿¡ µû¶ó ´õ¿í ºÐÇҵ˴ϴÙ.

ºÏ¹Ì´Â »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ Áö¿ªÀ̸ç, ¼±ÁøÀû ÇコÄɾî ÀÎÇÁ¶ó, ³ôÀº R&D ÅõÀÚ, ºÐÀÚÁø´Ü¿¡ ´ëÇÑ Á¤ºÎÀÇ °­·ÂÇÑ Áö¿ø¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ÀÓ»ó °Ë»ç½Ç, Çмú ¿¬±¸, ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ±â¾÷¿¡¼­ PCRÀÇ ±¤¹üÀ§ÇÑ Ã¤¿ë¿¡¼­ ÀÌ Áö¿ªÀ» ¸®µåÇϰí ÀÖ½À´Ï´Ù. Thermo Fisher Scientific°ú Bio-Rad Laboratories µî ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ´õ¿íÀÌ Äڷγª19¿Í °°Àº °Ç°­»ó ºñ»ó»çÅ ¼Ó¿¡¼­ ½Å¼ÓÁø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÌ Áö¿ªÀÇ ¸®´õ½ÊÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å, °­·ÂÇÑ ±ÔÁ¦ Ʋ, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶°¡ ºÏ¹Ì ½ÃÀåÀÇ ¿ìÀ§¼ºÀ» °è¼Ó µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾî Çʿ伺 Áõ°¡, Áø´Ü ÀÎÇÁ¶ó È®´ë, »ý¸í °øÇÐ ¿¬±¸ ÅõÀÚ Áõ°¡·Î »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀÇ Áö¹èÀû ¼¼·ÂÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀº Áö¿ªÀÇ Áø´Ü ´É·Â°ú »ý¸í°øÇÐ ±â¼ú Çõ½ÅÀ» µÞ¹ÞħÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÈûÀÔ¾î ÁÖ¿ä ±â¿© ¿äÀÎÀÔ´Ï´Ù. °¨¿°º´ À¯ÇàÀÇ ±Þ¼ÓÇÑ Áõ°¡¿Í Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ´ë°¡ ÁÖ¿ä ÃËÁø ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ȯÀÚ ¼ö°¡ ¸¹°í ºÐÀÚÁø´Ü¾à¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ºñ¿ë ¿ìÀ§¼º°ú ¼¼°èÀÇ ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ±â¾÷°úÀÇ Çù·Â °ü°èÀÇ Áõ°¡µµ, ½ÃÀåÀÇ ÁöÀ§¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå - °æÀï ±¸µµ

»ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀåÀº È®¸³µÈ Áø´Ü ´ë±â¾÷°ú ºÐÀÚ »ý¹°ÇÐÀÇ Àü¹® ±â¾÷ÀÇ À¶ÇÕ¿¡ ÀÇÇØ Çü¼ºµË´Ï´Ù. Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Agilent Technologies, Danaher Corporation µîÀÇ ´ë±â¾÷µéÀº °ß°íÇÑ R&D ÅõÀÚ, Æ÷°ýÀûÀÎ Á¦Ç° Æ÷Æ®Æú¸®¿À, ¼¼°èÀû À§»óÀ» ÅëÇØ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷Àº PCR ¿öÅ©Ç÷οìÀÇ Á¤È®µµ, ÀÚµ¿È­, ½ºÇǵ带 Áß½ÃÇØ °í¼º´É Áø´Ü¿¡ ´ëÇÑ ¼ö¿äÀÇ °íÁ¶¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ½ÅÈï ±â¾÷À̳ª Áö¿ªÀÇ À̳뺣ÀÌÅÍ´Â, ºñ¿ë È¿À²ÀÌ ¶Ù¾î³ª°í, À¯Àú ģȭÀûÀÎ Ç÷§Æû¿¡ ÁÖ·ÂÇØ, °æÀïÀ» °ÝÈ­½Ã۰í ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ, Àμö, ±â¼ú Çõ½ÅÀÌ ½ÃÀåÀÇ ÁøÈ­¸¦ ÃËÁøÇϰí Áø´Ü, ¿¬±¸, ¹ÙÀÌ¿À ±â¼ú ¿ëµµ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ý¹°ÇÐÀû PCR ±â¼úÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå »ý¹°ÇÐÀû PCR ±â¼ú »ê¾÷ ¿¬±¸

Á¦5Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå »óȲ

Á¦7Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : ±â¼úº°

Á¦9Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : ¿ëµµº°

Á¦10Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå »ý¹°ÇÐÀû PCR ±â¼ú ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : »ý¹°ÇÐÀû PCR ±â¼ú »ê¾÷

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Biological PCR Technology Market size was valued at USD 14,634.54 Million in 2024, expanding at a CAGR of 7.2% from 2024 to 2032.

Biological PCR (Polymerase Chain Reaction) technology is a molecular biology technique used to amplify specific DNA sequences. It enables researchers to generate millions of copies of a DNA fragment from a small initial sample, making it essential for genetic analysis, diagnostics, and research. The process involves repeated cycles of denaturation, annealing, and extension, facilitated by a thermostable DNA polymerase enzyme. PCR is widely used in medical diagnostics (e.g., detecting pathogens), forensic science, biotechnology, and evolutionary biology. Its precision, sensitivity, and speed make it a foundational tool for studying genetic material and conducting various biological and medical investigations.

Biological PCR Technology Market- Market Dynamics

Growing Demand for Rapid and Accurate Diagnostic Tools

The rising need for swift and precise diagnostic methods is a major driver for the biological PCR technology market. PCR's ability to detect minute amounts of genetic material with high specificity makes it invaluable in diagnosing infectious diseases, including COVID-19, HIV, and tuberculosis. As global health systems prioritize early disease detection and personalized medicine, PCR's role in clinical diagnostics continues to expand. Additionally, increased funding for healthcare infrastructure and technological advancements in PCR instruments further enhance its adoption across hospitals, laboratories, and research institutions, fueling steady market growth worldwide.

Biological PCR Technology Market- Key Insights

According to our research analyst, the global Biological PCR Technology Market is expected to develop at a CAGR of approximately 7.2% between 2024-2032.

Segmented by Product Type in 2024, the Reagents category dominated the market.

Based on Technique, the Real-Time PCR (qPCR) segment generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Biological PCR Technology Market- Segmentation Analysis:

The global Biological PCR Technology Market is divided into five categories: Product Type, Technique, Application, End User, and Region.

By product type, the biological PCR technology market is segmented into Reagents, Consumables, and Software & Services. Among these, Reagents dominate the market due to their critical role in every PCR reaction, including DNA primers, nucleotides, buffers, and enzymes. The high frequency of reagent usage in both research and diagnostic applications ensures consistent demand. Additionally, the rise in infectious disease testing, genetic research, and personalized medicine has significantly increased the volume of PCR tests conducted globally, further boosting reagent consumption. While consumables such as PCR tubes and plates are essential, and software & services contribute to data analysis and workflow automation, reagents remain the most revenue-generating segment due to their indispensable nature in PCR-based processes across laboratories and clinical settings.

By technique, the biological PCR technology market is segmented into Real-Time PCR, Conventional PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR, Multiplex PCR, and Other PCR Techniques. Among these, Real-Time PCR (qPCR) holds the dominant share due to its high sensitivity, speed, and quantitative capabilities. It allows real-time monitoring of DNA amplification, making it ideal for clinical diagnostics, infectious disease detection, and gene expression analysis. Its widespread use in COVID-19 testing significantly accelerated its adoption across the globe. Moreover, advancements in automation and integration with data analysis tools have made qPCR more accessible and reliable. While other techniques have niche applications, Real-Time PCR remains the most widely utilized due to its accuracy, efficiency, and versatility in both research and diagnostic settings.

Biological PCR Technology Market- Geographical Insights

Geographically, the Biological PCR Technology Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the biological PCR technology market, driven by advanced healthcare infrastructure, high R&D investments, and strong government support for molecular diagnostics. The United States leads the region with widespread adoption of PCR in clinical laboratories, academic research, and biotechnology firms. The presence of key market players, such as Thermo Fisher Scientific and Bio-Rad Laboratories, further strengthens market growth. Additionally, the demand for rapid diagnostic solutions amid health emergencies like COVID-19 has reinforced the region's leadership. Ongoing innovation, strong regulatory frameworks, and an increasing focus on personalized medicine continue to fuel North America's market dominance.

Asia Pacific is emerging as a dominant force in the biological PCR technology market due to its growing healthcare needs, expanding diagnostic infrastructure, and rising investment in biotechnology research. Countries like China, India, and Japan are leading contributors, supported by government initiatives to boost local diagnostic capabilities and biotech innovation. The rapid increase in infectious disease prevalence and the growing demand for early disease detection are key drivers. Additionally, the presence of a large patient population and rising awareness of molecular diagnostics contribute to market growth. The region's cost advantages and increasing collaborations with global biotech firms also enhance its market position.

Biological PCR Technology Market- Competitive Landscape:

The biological PCR technology market is shaped by a blend of established diagnostic giants and specialized molecular biology firms. Major players such as Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Agilent Technologies, and Danaher Corporation lead the space through robust R&D investments, comprehensive product portfolios, and global presence. These companies emphasize precision, automation, and speed in PCR workflows, meeting the growing demand for high-throughput diagnostics. Meanwhile, emerging firms and regional innovators are focusing on cost-effective, user-friendly platforms, intensifying competition. Strategic collaborations, acquisitions, and technological innovation drive the market's evolution and enhance its impact on diagnostics, research, and biotechnology applications.

Recent Developments:

In March 2024, Thermo Fisher Scientific Inc. launched the QuantStudio Absolute Q AutoRun PCR system, automating digital PCR workflows for enhanced precision and throughput in clinical and environmental testing.

In February 2024, Bio-Rad Laboratories, Inc. introduced the CFX Opus Deep Well Real-Time PCR System, expanding capacity for high-volume labs while maintaining accuracy in gene expression analysis and pathogen detection.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICAL PCR TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL BIOLOGICAL PCR TECHNOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOLOGICAL PCR TECHNOLOGY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOLOGICAL PCR TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Biological PCR Technology Market Overview

2. Executive Summary

3. Biological PCR Technology Key Market Trends

4. Biological PCR Technology Industry Study

5. Biological PCR Technology Market: Impact of Escalating Geopolitical Tensions

6. Biological PCR Technology Market Landscape

7. Biological PCR Technology Market - By Product Type

8. Biological PCR Technology Market - By Technique

9. Biological PCR Technology Market - By Application

10. Biological PCR Technology Market - By End User

11. Biological PCR Technology Market- By Geography

12. Key Vendor Analysis- Biological PCR Technology Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â